Induction and Activation of the Transcription Factor NFATc1 (NFAT2) Integrate RANKL Signaling in Terminal Differentiation of Osteoclasts

The versatility and universality of calcium signalling

Berridge, M. J., Lipp, P., & Bootman, M. D. (2000) · Nature Reviews Molecular Cell Biology · doi:10.1038/35036035 · Cited by 5,701 · see citing works

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.

Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439 · see citing works

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.

Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130 · see citing works

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3597 · Cited by 4,224 · see citing works

Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes

Liu, J., Farmer, J. D., Lane, W. S., Friedman, J., Weissman, I., & Schreiber, S. L. (1991) · Cell · doi:10.1016/0092-8674(91)90124-h · Cited by 4,116 · see citing works

Bone Resorption by Osteoclasts

Teitelbaum, S. L. (2000) · Science · doi:10.1126/science.289.5484.1504 · Cited by 3,962 · see citing works

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis.

Kong, Y.-Y., Yoshida, H., Sarosi, I., Tan, H.-L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., et al. (1999) · Nature · doi:10.1038/16852 · Cited by 3,351 · see citing works

TRANSCRIPTION FACTORS OF THE NFAT FAMILY:Regulation and Function

Rao, A., Luo, C. H., & Hogan, P. G. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.707 · Cited by 2,605 · see citing works

Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis

Manolagas, S. C. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.2.0395 · Cited by 2,575 · see citing works

Modulation of Osteoclast Differentiation and Function by the New Members of the Tumor Necrosis Factor Receptor and Ligand Families

Suda, T., Takahashi, N., Udagawa, N., Jimi, E., Gillespie, M. T., & Martin, T. J. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0367 · Cited by 2,317 · see citing works

Calcium oscillations increase the efficiency and specificity of gene expression

Dolmetsch, R. E., Xu, K., & Lewis, R. S. (1998) · Nature · doi:10.1038/31960 · Cited by 1,896 · see citing works

The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene

Yoshida, H., Hayashi, S.-I., Kunisada, T., Ogawa, M., Nishikawa, S., Okamura, H., Sudo, T., Shultz, L. D., & Nishikawa, S.-I. (1990) · Nature · doi:10.1038/345442a0 · Cited by 1,789 · see citing works

Therapeutic Approaches to Bone Diseases

Rodan, G. A., & Martin, T. J. (2000) · Science · doi:10.1126/science.289.5484.1508 · Cited by 1,767 · see citing works

Differential activation of transcription factors induced by Ca2+ response amplitude and duration

Dolmetsch, R. E., Lewis, R. S., Goodnow, C. C., & Healy, J. I. (1997) · Nature · doi:10.1038/386855a0 · Cited by 1,754 · see citing works

Reaching a Genetic and Molecular Understanding of Skeletal Development

Karsenty, G., & Wagner, E. F. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00157-0 · Cited by 1,594 · see citing works

Differential activation of transcription factors induced by Ca2+ response amplitude and duration

Dolmetsch, R. E., Lewis, R. S., Goodnow, C. C., & Healy, J. I. (1997) · Nature · doi:10.1038/40912 · Cited by 1,521 · see citing works

TNF-α induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand

Lam, J., Takeshita, S., Barker, J. E., Kanagawa, O., Ross, F. P., & Teitelbaum, S. L. (2000) · Journal of Clinical Investigation · doi:10.1172/jci11176 · Cited by 1,440 · see citing works

T-Cell mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ.

Takayanagi, H., Ogasawara, K., Hida, S., Chiba, T., Murata, S., Sato, K., Takaoka, A., Yokochi, T., Oda, H., Tanaka, K., et al. (2000) · Nature · doi:10.1038/35046102 · Cited by 1,358 · see citing works

NFAT Signaling

Crabtree, G. R., & Olson, E. N. (2002) · Cell · doi:10.1016/s0092-8674(02)00699-2 · Cited by 1,323 · see citing works

TRAF6 is a signal transducer for interleukin-1

Cao, Z., Xiong, J., Takeuchi, M., Kurama, T., & Goeddel, D. V. (1996) · Nature · doi:10.1038/383443a0 · Cited by 1,305 · see citing works

c-Fos: a Key Regulator of Osteoclast-Macrophage Lineage Determination and Bone Remodeling

Grigoriadis, A. E., Wang, Z., Cecchini, M. G., Hofstetter, W., Felix, R., Fleisch, H. A., & Wagner, E. F. (1994) · Science · doi:10.1126/science.7939685 · Cited by 1,260 · see citing works

The kinase TAK1 can activate the NIK-IκB as well as the MAP kinase cascade in the IL-1 signalling pathway

Ninomiya‐Tsuji, J., Kishimoto, K., Hiyama, A., Inoue, J., Cao, Z., & Matsumoto, K. (1999) · Nature · doi:10.1038/18465 · Cited by 1,187 · see citing works

Requirement for NF-κB in osteoclast and B-cell development

Franzoso, G., Carlson, L., Xing, L., Poljak, L., Shores, E. W., Brown, K. D., Leonardi, A., Tran, T., Boyce, B. F., & Siebenlist, U. (1997) · Genes & Development · doi:10.1101/gad.11.24.3482 · Cited by 996 · see citing works

Identification of a Putative Regulator of Early T Cell Activation Genes

Shaw, J., Utz, P. J., Durand, D. B., Toole, J. J., Emmel, E. A., & Crabtree, G. R. (1988) · Science · doi:10.1126/science.3260404 · Cited by 946 · see citing works

RANK-L and RANK: T Cells, Bone Loss, and Mammalian Evolution

Theill, L. E., Boyle, W. J., & Penninger, J. M. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064753 · Cited by 817 · see citing works

Partners in transcription: NFAT and AP-1

Macián, F., López‐Rodríguez, C., & Rao, A. (2001) · Oncogene · doi:10.1038/sj.onc.1204386 · Cited by 766 · see citing works

Bcl2 Regulation by the Melanocyte Master Regulator Mitf Modulates Lineage Survival and Melanoma Cell Viability

McGill, G. G., Horstmann, M. A., Widlund, H. R., Du, J., Motyckova, G., Nishimura, E. K., Lin, Y., Ramaswamy, S., Avery, W., Ding, H., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)00762-6 · Cited by 760 · see citing works

The osteoclast differentiation factor osteoprotegerin ligand is essential for mammary gland development.

Fata, J. E., Kong, Y.-Y., Li, J., Sasaki, T., Irie-Sasaki, J., Moorehead, R. A., Elliott, R., Scully, S., Voura, E. B., Lacey, D. L., et al. (2000) · Cell · doi:10.1016/s0092-8674(00)00103-3 · Cited by 756 · see citing works

RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-β

Takayanagi, H., Kim, S., Matsuo, K., Suzuki, H. I., Suzuki, T., Sato, K., Yokochi, T., Oda, H., Nakamura, K., Ida, N., et al. (2002) · Nature · doi:10.1038/416744a · Cited by 719 · see citing works

Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor κB (RANK) receptors.

Arai, F., Miyamoto, T., Ohneda, O., Inada, T., Sudo, T., Brasel, K., Miyata, T., Anderson, D. M., & Suda, T. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.12.1741 · Cited by 693 · see citing works

Role of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum

de la Pompa, J. L., Timmerman, L. A., Takimoto, H., Yoshida, H., Elia, A. J., Samper, E., Potter, J., Wakeham, A., Marengere, L., Langille, B. L., et al. (1998) · Nature · doi:10.1038/32419 · Cited by 660 · see citing works

Osteoclast differentiation factor is a ligand for osteoprotegerin/ osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 95: 3597-602

Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Cited by 650 · see citing works

Severe osteopetrosis, defective interleukin‐1 signalling and lymph node organogenesis in TRAF6‐deficient mice

Naito, A., Azuma, S., Tanaka, S., Miyazaki, T., Takaki, S., Takatsu, K., Nakao, K., Nakamura, K., Katsuki, M., Yamamoto, T. S., et al. (1999) · Genes to Cells · doi:10.1046/j.1365-2443.1999.00265.x · Cited by 626 · see citing works

The transcription factor NF-ATc is essential for cardiac valve formation

Ranger, A. M., Grusby, M. J., Hodge, M. R., Gravallese, E. M., de la Brousse, F. C., Hoey, T., Mickanin, C., Baldwin, H. S., & Glimcher, L. H. (1998) · Nature · doi:10.1038/32426 · Cited by 586 · see citing works

Osteopetrosis in mice lacking haematopoietic transcription factor PU.1

Tondravi, M. M., McKercher, S. R., Anderson, K., Erdmann, J. M., Quiroz, M. E., Maki, R. A., & Teitelbaum, S. L. (1997) · Nature · doi:10.1038/386081a0 · Cited by 537 · see citing works

Rapid shuttling of NF-AT in discrimination of Ca2+ signals and immunosuppression

Timmerman, L., Clipstone, N. A., Ho, S. N., Northrop, J. P., & Crabtree, G. R. (1996) · Nature · doi:10.1038/383837a0 · Cited by 528 · see citing works

Structure of the DNA-binding domains from NFAT, Fos and Jun bound specifically to DNA

Chen, L., Glover, J. N. M., Hogan, P. G., Rao, A., & Harrison, S. C. (1998) · Nature · doi:10.1038/32100 · Cited by 521 · see citing works

Segregation of TRAF6‐mediated signaling pathways clarifies its role in osteoclastogenesis

Kobayashi, N., Kadono, Y., Naito, A., Matsumoto, K., Yamamoto, T. S., Tanaka, S., & Inoue, J. (2001) · The EMBO Journal · doi:10.1093/emboj/20.6.1271 · Cited by 467 · see citing works

The TRAF Family of Signal Transducers Mediates NF-κB Activation by the TRANCE Receptor

Wong, B. R., Josien, R., Lee, S. Y., Vologodskaia, M., Steinman, R. M., & Choi, Y. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.43.28355 · Cited by 458 · see citing works

Large Scale Gene Expression Analysis of Osteoclastogenesisin Vitro and Elucidation of NFAT2 as a Key Regulator

Ishida, N., Hayashi, K., Hoshijima, M., Ogawa, T., Koga, S., Miyatake, Y., Kumegawa, M., Kimura, T., & Takeya, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205063200 · Cited by 377 · see citing works

Directed evolution of green fluorescent protein by a new versatile PCR strategy for site-directed and semi-random mutagenesis

Sakaue-Sawano, A. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.16.e78 · Cited by 356 · see citing works

Fosl1 is a transcriptional target of c-Fos during osteoclast differentiation

Matsuo, K., Owens, J., Tonko, M., Elliott, C., Chambers, T. J., & Wagner, E. F. (2000) · Nature Genetics · doi:10.1038/72855 · Cited by 341 · see citing works

The Transcription Factor NF-ATc1 Regulates Lymphocyte Proliferation and Th2 Cytokine Production

Yoshida, H., Nishina, H., Takimoto, H., Marengère, L. E. M., Wakeham, A. C., Bouchard, D., Kong, Y., Ohteki, T., Shahinian, A., Bachmann, M. F., et al. (1998) · Immunity · doi:10.1016/s1074-7613(00)80464-1 · Cited by 339 · see citing works

Gene expression elicited by NFAT in the presence or absence of cooperative recruitment of Fos and Jun

Macián, F., García‐Rodríguez, C., & Rao, A. (2000) · The EMBO Journal · doi:10.1093/emboj/19.17.4783 · Cited by 329 · see citing works

Enforced Expression of Bcl-2 in Monocytes Rescues Macrophages and Partially Reverses Osteopetrosis in op/op Mice

Lagasse, E., & Weissman, I. L. (1997) · Cell · doi:10.1016/s0092-8674(00)80290-1 · Cited by 287 · see citing works

Frequency and predictors of osteoporotic fractures after cardiac or liver transplantation: a follow-up study

Leidig‐Bruckner, G., Hosch, S., Dodidou, P., Ritschel, D., Conradt, C., Klose, C., Otto, G., Lange, R., Lorenz Theilmann, I., Zimmerman, R., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03641-2 · Cited by 262 · see citing works

THE DELETERIOUS EFFECTS OF LONG-TERM CYCLOSPORINE A, CYCLOSPORINE G, AND FK506 ON BONE MINERAL METABOLISM IN VIVO

Cvetković, M., Mann, G. N., Romero, D. F., Liang, X. G., Ma, Y., Jee, W. S. S., & Epstein, S. (1994) · Transplantation · doi:10.1097/00007890-199404270-00016 · Cited by 246 · see citing works

Phosphatidylinositol 3-Kinase in Interleukin 1 Signaling

Reddy, S. A. G., Huang, J. H., & Liao, W. S. ‐. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.46.29167 · Cited by 230 · see citing works

Genetic control of skeletal development

Wagner, E. F., & Karsenty, G. (2001) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(00)00228-8 · Cited by 226 · see citing works

Linking osteopetrosis and pycnodysostosis: Regulation of cathepsin K expression by the microphthalmia transcription factor family

Motyckova, G., Weilbaecher, K. N., Horstmann, M. A., Rieman, D. J., Fisher, D. E., & Fisher, D. E. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091479298 · Cited by 220 · see citing works

Linkage of M-CSF Signaling to Mitf, TFE3, and the Osteoclast Defect in Mitfmi/mi Mice

Weilbaecher, K. N., Motyckova, G., Huber, W. E., Takemoto, C. M., Hemesath, T. J., Xu, Y., Hershey, C. L., Dowland, N., Wells, A. G., & Fisher, D. E. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00360-4 · Cited by 168 · see citing works

Early Events in M-CSF Receptor Signaling

Bourette, R. P., & Rohrschneider, L. R. (2000) · Growth Factors · doi:10.3109/08977190009001065 · Cited by 125 · see citing works

Regulation of the Murine Nfatc1 Gene by NFATc2

Zhou, B., Cron, R. Q., Wu, B., Genin, A., Wang, Z., Liu, S., Robson, P., & Baldwin, H. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107068200 · Cited by 124 · see citing works

T lymphocytes play a critical role in the development of cyclosporin A- induced osteopenia

Buchinsky, F. J., Ma, Y. F., Mann, G. N., Rucinski, B., Bryer, H. P., Romero, D. F., Jee, W. S. S., & Epstein, S. (1996) · Endocrinology · doi:10.1210/endo.137.6.8641176 · Cited by 113 · see citing works

Conditional requirement for the Flk-1 receptor in the in vitro generation of early hematopoietic cells

Hidaka, M., Stanford, W. L., & Bernstein, A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7370 · Cited by 112 · see citing works

Interfering with bone remodelling

Alliston, T. N., & Derynck, R. (2002) · Nature · doi:10.1038/416686a · Cited by 91 · see citing works

Characterization of the mouse tartrate-resistant acid phosphatase (trap) gene promoter

Reddy, S. V., Hundley, J. E., Windle, J. J., Alcantara, O., Linn, R. A., Leach, R. J., Boldt, D. H., & Roodman, G. D. (1995) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650100413 · Cited by 85 · see citing works

The effect of environmental cues on the differentiation of myofibroblasts in peritoneal granulation tissue

(2000) · doi:10.1002/1096-9896(2000)9999:9999 · Cited by 70 · see citing works

Tissue-specific and Ubiquitous Promoters Direct the Expression of Alternatively Spliced Transcripts from the Calcitonin Receptor Gene

Anusaksathien, O., Laplace, C., Li, X., Ren, Y., Peng, L., Goldring, S. R., & Galson, D. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007104200 · Cited by 67 · see citing works

Recombinant human tumor necrosis factor alpha induces calcium oscillation and calcium-activated chloride current in human neutrophils. The role of calcium/calmodulin-dependent protein kinase.

Schumann, M. A., Gardner, P., & Raffin, T. A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53972-7 · Cited by 55 · see citing works

Carbonic anhydrase II is an AP‐1 target gene in osteoclasts

David, J. ‐., Rincón, M., Neff, L., Horne, W. C., & Baron, R. (2001) · Journal of Cellular Physiology · doi:10.1002/jcp.1099 · Cited by 50 · see citing works

NF-ATc Isoforms Are Differentially Expressed and Regulated in Murine T and Mast Cells

Sherman, M. A., Powell, D. R., Weiss, D. L., et al. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.5.2820 · Cited by 29 · see citing works

The effects of interferon-beta treatment of synovial inflammation and expression of metalloproteinases in patients with rheumatoid arthritis

Gravellese (2000) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200002)43:2 · Cited by 2 · see citing works

Osteoclast differentiation and activation

Boyle, W. J., Simonet, W. S., & Lacey, D. L. (2003) · Nature · doi:10.1038/nature01658 · Cited by 6,670 · see citing works

Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems

Takayanagi, H. (2007) · Nature Reviews Immunology · doi:10.1038/nri2062 · Cited by 1,878 · see citing works

Functions of RANKL/RANK/OPG in bone modeling and remodeling

Boyce, B. F., & Xing, L. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.03.018 · Cited by 1,844 · see citing works

Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction

Sato, K., Suematsu, A., Okamoto, K., Yamaguchi, A., Morishita, Y., Kadono, Y., Tanaka, S., Kodama, T., Akira, S., Iwakura, Y., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061775 · Cited by 1,554 · see citing works

BIOMECHANICAL AND MOLECULAR REGULATION OF BONE REMODELING

Robling, A. G., Castillo, A. B., & Turner, C. H. (2006) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.8.061505.095721 · Cited by 1,343 · see citing works

Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis

Komatsu, N., Okamoto, K., Sawa, S., Nakashima, T., Oh-hora, M., Kodama, T., Tanaka, S., Bluestone, J. A., & Takayanagi, H. (2014) · Nature Medicine · doi:10.1038/nm.3432 · Cited by 1,153 · see citing works

Skeletal remodeling in health and disease

Zaidi, M. (2007) · Nature Medicine · doi:10.1038/nm1593 · Cited by 1,069 · see citing works

DC-STAMP is essential for cell–cell fusion in osteoclasts and foreign body giant cells

Yagi, M., Miyamoto, T., Sawatani, Y., Iwamoto, K., Hosogane, N., Fujita, N., Morita, K., Ninomiya, K., Suzuki, T., Miyamoto, K., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050645 · Cited by 890 · see citing works

Autoamplification of NFATc1 expression determines its essential role in bone homeostasis

Asagiri, M., Sato, K., Usami, T., Ochi, S., Nishina, H., Yoshida, H., Morita, I., Wagner, E. F., Mak, T. W., Serfling, E., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051150 · Cited by 849 · see citing works

Osteoclast–osteoblast communication

Matsuo, K., & Irie, N. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.03.027 · Cited by 780 · see citing works

Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis

Zhao, C., Irie, N., Takada, Y., Shimoda, K., Miyamoto, T., Nishiwaki, T., Suda, T., & Matsuo, K. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.05.012 · Cited by 777 · see citing works

OSTEOIMMUNOLOGY: Interplay Between the Immune System and Bone Metabolism

Walsh, M. C., Kim, N., Kadono, Y., Rho, J., Lee, S. Y., Lorenzo, J., & Choi, Y. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090646 · Cited by 724 · see citing works

Osteoclasts: What Do They Do and How Do They Do It?

Teitelbaum, S. L. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.060834 · Cited by 730 · see citing works

Transforming Growth Factor-β1 to the Bone

Janssens, K., ten Dijke, P., Janssens, S., & Van Hul, W. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0001 · Cited by 710 · see citing works

The cell biology of bone metabolism

Datta, H. K., Ng, W. F., Walker, J. A., Tuck, S. P., & Varanasi, S. S. (2008) · Journal of Clinical Pathology · doi:10.1136/jcp.2007.048868 · Cited by 614 · see citing works

Osteoprotection by semaphorin 3A

Hayashi, M., Nakashima, T., Taniguchi, M., Kodama, T., Kumanogoh, A., & Takayanagi, H. (2012) · Nature · doi:10.1038/nature11000 · Cited by 606 · see citing works

Biology of the RANKL–RANK–OPG System in Immunity, Bone, and Beyond

Walsh, M. C., & Choi, Y. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00511 · Cited by 599 · see citing works

Regulation of NFATc1 in Osteoclast Differentiation

Kim, J. H., & Kim, N. (2014) · Journal of Bone Metabolism · doi:10.11005/jbm.2014.21.4.233 · Cited by 570 · see citing works

Establishment and Maintenance of the Macrophage Niche

Guilliams, M., Thierry, G. R., Bonnardel, J., & Bajenoff, M. (2020) · Immunity · doi:10.1016/j.immuni.2020.02.015 · Cited by 512 · see citing works

Suppression of bone formation by osteoclastic expression of semaphorin 4D

Negishi-Koga, T., Shinohara, M., Komatsu, N., Bito, H., Kodama, T., Friedel, R. H., & Takayanagi, H. (2011) · Nature Medicine · doi:10.1038/nm.2489 · Cited by 498 · see citing works

Developmental origin, functional maintenance and genetic rescue of osteoclasts

Jacome-Galarza, C. E., Percin, G. I., Muller, J. T., Mass, E., Lazarov, T., Eitler, J., Rauner, M., Yadav, V. K., Crozet, L., Bohm, M., et al. (2019) · Nature · doi:10.1038/s41586-019-1105-7 · Cited by 475 · see citing works

Bone remodeling: an operational process ensuring survival and bone mechanical competence

Bolamperti, S., Villa, I., & Rubinacci, A. (2022) · Bone Research · doi:10.1038/s41413-022-00219-8 · Cited by 482 · see citing works

Essential Role of p38 Mitogen-activated Protein Kinase in Cathepsin K Gene Expression during Osteoclastogenesis through Association of NFATc1 and PU.1

Matsumoto, M., Kogawa, M., Wada, S., Takayanagi, H., Tsujimoto, M., Katayama, S., Hisatake, K., & Nogi, Y. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408795200 · Cited by 436 · see citing works

The role of NFAT in osteoclast formation

TAKAYANAGI, H. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1402.071 · Cited by 442 · see citing works

RANK/RANKL: Regulators of Immune Responses and Bone Physiology

Leibbrandt, A., & Penninger, J. M. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1443.016 · Cited by 420 · see citing works

Mechanistic insight into osteoclast differentiation in osteoimmunology

Takayanagi, H. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-004-0612-6 · Cited by 413 · see citing works

The RANKL/RANK/OPG pathway

Boyce, B. F., & Xing, L. (2007) · Current Osteoporosis Reports · doi:10.1007/s11914-007-0024-y · Cited by 339 · see citing works

Paget disease of bone.

Roodman, G. D., & Windle, J. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24281 · Cited by 340 · see citing works

The Atypical PKC-Interacting Protein p62 Is an Important Mediator of RANK-Activated Osteoclastogenesis

Durán, A., Serrano, M., Leitges, M., Flores, J. M., Picard, S., Brown, J. P., Moscat, J., & Diaz-Meco, M. T. (2004) · Developmental Cell · doi:10.1016/s1534-5807(03)00403-9 · Cited by 316 · see citing works

Regulation of TNF-Induced Osteoclast Differentiation

Yao, Z., Getting, S. J., & Locke, I. C. (2021) · Cells · doi:10.3390/cells11010132 · Cited by 280 · see citing works

Hypoxia and Hypoxia-Inducible Factor-1 Expression Enhance Osteolytic Bone Metastases of Breast Cancer

Hiraga, T., Kizaka-Kondoh, S., Hirota, K., Hiraoka, M., & Yoneda, T. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2355 · Cited by 242 · see citing works

Negative regulation of osteoclastogenesis by ectodomain shedding of receptor activator of NF-κB ligand.

Hikita, A., Yana, I., Wakeyama, H., Nakamura, M., Kadono, Y., Oshima, Y., Nakamura, K., Seiki, M., & Tanaka, S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m606656200 · Cited by 236 · see citing works

PU.1 target genes undergo Tet2-coupled demethylation and DNMT3b-mediated methylation in monocyte-to-osteoclast differentiation

de la Rica, L., Rodríguez-Ubreva, J., García, M., Islam, A. B., Urquiza, J. M., Hernando, H., Christensen, J., Helin, K., Gómez-Vaquero, C., & Ballestar, E. (2013) · Genome Biology · doi:10.1186/gb-2013-14-9-r99 · Cited by 211 · see citing works

PLCγ2 regulates osteoclastogenesis via its interaction with ITAM proteins and GAB2

Mao, D., Epple, H., Uthgenannt, B., Novack, D. V., & Faccio, R. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28775 · Cited by 214 · see citing works

RANKL/OPG; Critical role in bone physiology

Martin, T. J., & Sims, N. A. (2015) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-014-9308-6 · Cited by 213 · see citing works

RANKL as the master regulator of osteoclast differentiation

Takayanagi, H. (2021) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-020-01191-1 · Cited by 175 · see citing works

Bone cell interactions through Eph/ephrin: Bone modeling, remodeling and associated diseases

Matsuo, K., & Otaki, N. (2012) · Cell Adhesion & Migration · doi:10.4161/cam.20888 · Cited by 167 · see citing works

The intracellular domain of CD44 promotes the fusion of macrophages

Cui, W. (2006) · Blood · doi:10.1182/blood-2005-05-1902 · Cited by 110 · see citing works

The origins and formation of bone-resorbing osteoclasts

Elson, A., Anuj, A., Barnea-Zohar, M., & Reuven, N. (2022) · Bone · doi:10.1016/j.bone.2022.116538 · Cited by 95 · see citing works

Steap4 Plays a Critical Role in Osteoclastogenesis in Vitro by Regulating Cellular Iron/Reactive Oxygen Species (ROS) Levels and cAMP Response Element-binding Protein (CREB) Activation

Zhou, J., Ye, S., Fujiwara, T., Manolagas, S. C., & Zhao, H. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.478750 · Cited by 88 · see citing works

PU.1 and NFATc1 mediate osteoclastic induction of the mouse β₃ integrin promoter

Crotti, T. N., Sharma, S. M., Fleming, J. D., Flannery, M. R., Ostrowski, M. C., Goldring, S. R., & McHugh, K. P. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21344 · Cited by 76 · see citing works

Thymidine phosphorylase exerts complex effects on bone resorption and formation in myeloma

Liu, H., Liu, Z., Du, J., He, J., Lin, P., Amini, B., Starbuck, M. W., Novane, N., Shah, J. J., Davis, R. E., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad8949 · Cited by 74 · see citing works

The Nuclear Receptor AhR Controls Bone Homeostasis by Regulating Osteoclast Differentiation via the RANK/c-Fos Signaling Axis

Izawa, T., Arakaki, R., Mori, H., Tsunematsu, T., Kudo, Y., Tanaka, E., & Ishimaru, N. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600822 · Cited by 64 · see citing works

Role and Regulation of Transcription Factors in Osteoclastogenesis

Jiang, T., Xia, T., Qiao, F., Wang, N., Jiang, Y., & Xin, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216175 · Cited by 60 · see citing works

The Matricellular Protein CYR61 Inhibits Osteoclastogenesis by a Mechanism Independent of αvβ3 and αvβ5

Crockett, J. C., Schütze, N., Tosh, D., Jatzke, S., Duthie, A., Jakob, F., & Rogers, M. J. (2007) · Endocrinology · doi:10.1210/en.2007-0473 · Cited by 57 · see citing works

Kynurenine Promotes RANKL-Induced Osteoclastogenesis In Vitro by Activating the Aryl Hydrocarbon Receptor Pathway

Eisa, N. H., Reddy, S. V., Elmansi, A. M., Kondrikova, G., Kondrikov, D., Shi, X.-M., Novince, C. M., Hamrick, M. W., McGee-Lawrence, M. E., Isales, C. M., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21217931 · Cited by 55 · see citing works

Wnt16 regulates osteoclast differentiation in conjunction with Wnt5a

Kobayashi, Y., Thirukonda, G. J., Nakamura, Y., Koide, M., Yamashita, T., Uehara, S., Kato, H., Udagawa, N., & Takahashi, N. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.06.102 · Cited by 47 · see citing works

Ovariectomy-induced bone loss in TNFα and IL6 gene knockout mice is regulated by different mechanisms

Zhu, S., He, H., Gao, C., Luo, G., Xie, Y., Wang, H., Tian, L., Chen, X., Yu, X., & He, C. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-17-0218 · Cited by 44 · see citing works

Cooperation of PU.1 With IRF8 and NFATc1 Defines Chromatin Landscapes During RANKL-Induced Osteoclastogenesis

Izawa, N., Kurotaki, D., Nomura, S., Fujita, T., Omata, Y., Yasui, T., Hirose, J., Matsumoto, T., Saito, T., Kadono, Y., et al. (2019) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3689 · Cited by 40 · see citing works

AMPK negatively regulates RANKL-induced osteoclast differentiation by controlling oxidative stress

Tanaka, M., Inoue, H., Takahashi, N., & Uehara, M. (2023) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2023.05.033 · Cited by 41 · see citing works

Enhancer variants reveal a conserved transcription factor network governed by PU.1 during osteoclast differentiation

Carey, H. A., Hildreth, B. E., Geisler, J. A., Nickel, M. C., Cabrera, J., Ghosh, S., Jiang, Y., Yan, J., Lee, J., Makam, S., et al. (2018) · Bone Research · doi:10.1038/s41413-018-0011-1 · Cited by 40 · see citing works

Protection against arthritis by the parasitic worm product ES-62, and its drug-like small molecule analogues, is associated with inhibition of osteoclastogenesis

Doonan, J., Lumb, F. E., Pineda, M. A., Tarafdar, A., Crowe, J., Khan, A. M., Suckling, C. J., Harnett, M. M., & Harnett, W. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01016 · Cited by 38 · see citing works

STAC2 negatively regulates osteoclast formation by targeting the RANK signaling complex

Jeong, E., Choi, H. K., Park, J. H., & Lee, S. Y. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0048-5 · Cited by 35 · see citing works

The Role of Toll-Like Receptors in Osteoclastogenesis

Yim, M. (2020) · Journal of Bone Metabolism · doi:10.11005/jbm.2020.27.4.227 · Cited by 28 · see citing works

Lhx2 regulates bone remodeling in mice by modulating RANKL signaling in osteoclasts

Kim, J. H., Youn, B. U., Kim, K., Moon, J. B., Lee, J., Nam, K.-I. I., Park, Y.-W., O'Leary, D. D. M., Kim, K. K., & Kim, N. (2014) · Cell Death & Differentiation · doi:10.1038/cdd.2014.71 · Cited by 26 · see citing works

Phospholipase Cγ2 Mediates RANKL-stimulated Lymph Node Organogenesis and Osteoclastogenesis

Chen, Y., Wang, X., Di, L., Fu, G., Chen, Y., Bai, L., Liu, J., Feng, X., McDonald, J. M., Michalek, S., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802493200 · Cited by 27 · see citing works

Activating; ‐catenin/Pax6 axis negatively regulates osteoclastogenesis by selectively inhibiting phosphorylation of p38/MAPK

Jie, Z., Shen, S., Zhao, X., Xu, W., Zhang, X., Huang, B., Tang, P., Qin, A., Fan, S., & Xie, Z. (2019) · The FASEB Journal · doi:10.1096/fj.201801977r · Cited by 22 · see citing works

Transcriptionally active nuclei are selective in mature multinucleated osteoclasts

Youn, M., Takada, I., Imai, Y., Yasuda, H., & Kato, S. (2010) · Genes to Cells · doi:10.1111/j.1365-2443.2010.01441.x · Cited by 22 · see citing works

SIRT2 deficiency prevents age-related bone loss in rats by inhibiting osteoclastogenesis

Jing, Y., Zhou, Y., Zhou, F., Wang, X., Tao, B., Sun, L., Liu, J., & Zhao, H. (2019) · Cellular and Molecular Biology · doi:10.14715/cmb/2019.65.7.12 · Cited by 22 · see citing works

Remifentanil negatively regulates RANKL-induced osteoclast differentiation and bone resorption by inhibiting c-Fos/NFATc1 expression

Yoon, J.-Y., Baek, C.-W., Kim, H.-J., Kim, E.-J., Byeon, G.-J., & Yoon, J.-U. (2018) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-018-0116-z · Cited by 17 · see citing works

The intricate mechanism of PLS3 in bone homeostasis and disease

Zhong, W., Pathak, J. L., Liang, Y., Zhytnik, L., Pals, G., Eekhoff, E. M. W., Bravenboer, N., & Micha, D. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1168306 · Cited by 13 · see citing works

MiRNAs Expression Profiling in Raw264.7 Macrophages after Nfatc1-Knockdown Elucidates Potential Pathways Involved in Osteoclasts Differentiation

Russo, R., Zito, F., & Lampiasi, N. (2021) · Biology · doi:10.3390/biology10111080 · Cited by 6 · see citing works

Effect of remifentanil on pre-osteoclast cell differentiation in vitro

Jeon, H.-O., Choi, I.-S., Yoon, J.-Y., Kim, E.-J., Yoon, J.-U., Cho, A.-R., Kim, H.-J., & Kim, C.-H. (2018) · Journal of Dental Anesthesia and Pain Medicine · doi:10.17245/jdapm.2018.18.1.9 · Cited by 4 · see citing works

Molecular Modeling and Structure-Based Design of Direct Calcineurin Inhibitors

Hou, X., Tatlock, J. H., Linton, M. A., et al. (2000) · Springer eBooks · doi:10.1007/978-1-4615-4141-7_88

Increased Regulatory Activity of the Calcineurin/NFAT Pathway in Human Heart Failure

Diedrichs, H., Chi, M., Boelck, B., Mehlhorm, U., & Schwinger, R. H. G. (2003) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2003.07.007 · Cited by 73 · see citing works

Dose‐Dependent Transcriptional Regulation by the Calcineurin/NFAT Signaling in Developing Myocardium Transition

Yang, X., Yang, T. T. C., Schubert, W., et al. (2006) · The FASEB Journal · doi:10.1096/fasebj.20.5.lb74-b

RCAN-11R peptide provides immunosuppression for fully mismatched islet allografts in mice

Noguchi, H., Sugimoto, K., Miyagi‐Shiohira, C., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-02934-3 · Cited by 20 · see citing works

Does Contractile Ca 2+ Control Calcineurin-NFAT Signaling and Pathological Hypertrophy in Cardiac Myocytes?

Houser, S. R., & Molkentin, J. D. (2008) · Science Signaling · doi:10.1126/scisignal.125pe31 · Cited by 101 · see citing works